Chesnara Plc: Fourth acquisition in two years
12 November 2026
Ardelyx, Inc. (NASDAQ: ARDX), a prominent player in the biotechnology sector, is catching the eye of investors with its substantial potential upside of 91.47%. This Massachusetts-based..
Oculis Holding AG (OCS) is capturing the attention of investors with its promising pipeline and substantial potential upside. As a clinical-stage biopharmaceutical company specializing in ophthalmic..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a notable player in the healthcare sector, specifically within the drug manufacturing industry for specialty and generic products...
Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, has been turning heads in the healthcare sector with its innovative approach to biotherapeutics targeting cancer and autoimmune..
For investors seeking opportunities in the biotechnology sector, Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) presents an intriguing proposition. With a market capitalization of $1.27 billion, this commercial-stage..
Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid industry, is navigating the evolving landscape of healthcare with a strategic focus on cannabis products...
Niagen Bioscience, Inc. (NAGE), a prominent player in the biotechnology sector, presents a compelling investment opportunity for those looking to capitalize on the burgeoning healthcare market...
CareDx, Inc. (NASDAQ: CDNA), a healthcare pioneer in the diagnostics and research sector, is attracting attention with its substantial potential upside of 87.82%. Specializing in diagnostic..
Investors with a keen eye on the biotechnology sector may find Pharvaris N.V. (NASDAQ: PHVS) a compelling prospect. With a market capitalization of $1.48 billion, this..
Intellia Therapeutics, Inc. (NTLA), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising gene-editing technologies and significant potential upside. As..
For investors seeking opportunities in the volatile yet promising biotech sector, Vir Biotechnology, Inc. (NASDAQ: VIR) presents a compelling case. While the company currently faces substantial..
CorMedix Inc. (NASDAQ: CRMD), with its focus on innovative biopharmaceutical solutions, stands as a compelling investment opportunity within the healthcare sector. The company’s strategic emphasis on..
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, has been capturing the attention of investors with its ambitious approach to cancer treatment...
Trevi Therapeutics, Inc. (NASDAQ: TRVI) presents an intriguing opportunity for investors eyeing the biotechnology sector. With a market capitalization of $912.11 million and a unique focus..
Gyre Therapeutics, Inc. (NASDAQ: GYRE) stands out in the biotechnology sector with a compelling promise of significant upside potential, drawing investor interest in the healthcare domain...
Embecta Corp. (NASDAQ: EMBC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing the attention of investors with..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a late-stage biotechnology company headquartered in Cranbury, New Jersey, commands attention with its promising gene therapy pipeline aimed at tackling rare..
InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, has been garnering attention from investors with its innovative approach to medical devices. Headquartered in..
Ringcentral, Inc. (NYSE: RNG), a prominent player in the Technology sector, specifically within the Software – Application industry, is recognized for its robust suite of cloud-based..
In the ever-evolving technology sector, Paycom Software, Inc. (NASDAQ: PAYC) stands out as a formidable player in the Software – Application industry, with a current market..
